5 results
8-K
EX-10.1
SAVA
Cassava Sciences Inc
22 Nov 22
Cassava Sciences Announces $50 Million Registered Direct Offering of Common Stock
12:49pm
of, requests the recall, suspension, or seizure of, or withdraws or orders the withdrawal of advertising or sales promotional materials relating to, any
8-K
EX-10.1
SAVA
Cassava Sciences Inc
11 Mar 21
Cassava Sciences Announces Pharmaceutical Supply Agreement for Simufilam
4:59pm
FOR EACH INDIVIDUAL STATEMENT OF WORK FOR ANY AND ALL CLAIMS WHATSOEVER INCLUDING ANY THIRD PARTY CLAIMS, PRODUCT RECALL, AND EVONIK’S INDEMNITY
8-K
EX-10.1
SAVA
Cassava Sciences Inc
12 Feb 21
Cassava Sciences Announces $200 Million Registered Direct Offering of Common Stock
5:09pm
, (ii) withdraws its approval of, requests the recall, suspension, or seizure of, or withdraws or orders the withdrawal of advertising or sales
8-K
EX-1.1
SAVA
Cassava Sciences Inc
13 Nov 20
Cassava Sciences Announces Proposed Public Offering of Common Stock
4:36pm
, conducted or issued, any recall, market withdrawal or replacement, safety alert, post sale warning, “dear healthcare provider” letter, or other
- Prev
- 1
- Next